Cargando…
Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
BACKGROUND: Recently, miR-451 as a tumor suppressor has been reported in other studies. However, whether miR-451 can affect the sensitivity of non-small cell lung cancer (NSCLC) cells to cisplatin (DDP) remains unclear. The aim of this study is to evaluate the roles of miR-451 in the sensitivity of...
Autores principales: | Bian, Hai-Bo, Pan, Xuan, Yang, Jin-Song, Wang, Zhao-Xia, De, Wei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051912/ https://www.ncbi.nlm.nih.gov/pubmed/21329503 http://dx.doi.org/10.1186/1756-9966-30-20 |
Ejemplares similares
-
Upregulation of microrna‐451 increases the sensitivity of A549 cells to radiotherapy through enhancement of apoptosis
por: Tian, Feng, et al.
Publicado: (2015) -
MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019) -
MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020) -
Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2
por: Pang, Linrong, et al.
Publicado: (2017) -
Upregulation of microRNA-451 attenuates myocardial I/R injury by suppressing HMGB1
por: Cao, Jianlei, et al.
Publicado: (2020)